- Home
- CVR vs HOOK Comparison
CVR vs HOOK Comparison
Compare CVR & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- HOOK
- Stock Information
- Founded
- CVR 1920
- HOOK 2011
- Country
- CVR United States
- HOOK United States
- Employees
- CVR N/A
- HOOK 87
- Industry
- CVR Industrial Machinery/Components
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- HOOK Health Care
- Exchange
- CVR Nasdaq
- HOOK Nasdaq
- Market Cap
- CVR 11.1M
- HOOK 15.3M
- IPO Year
- CVR N/A
- HOOK 2019
- Fundamental
- Price
- CVR $12.20
- HOOK $1.21
- Analyst Decision
- CVR
- HOOK Buy
- Analyst Count
- CVR 0
- HOOK 4
- Target Price
- CVR N/A
- HOOK $10.67
- AVG Volume (30 Days)
- CVR 4.4K
- HOOK 65.6K
- Earning Date
- CVR 08-12-2025
- HOOK 08-07-2025
- Dividend Yield
- CVR 0.96%
- HOOK N/A
- EPS Growth
- CVR N/A
- HOOK N/A
- EPS
- CVR N/A
- HOOK N/A
- Revenue
- CVR $26,379,081.00
- HOOK $9,351,000.00
- Revenue This Year
- CVR N/A
- HOOK N/A
- Revenue Next Year
- CVR N/A
- HOOK N/A
- P/E Ratio
- CVR N/A
- HOOK N/A
- Revenue Growth
- CVR N/A
- HOOK N/A
- 52 Week Low
- CVR $8.15
- HOOK $0.72
- 52 Week High
- CVR $22.27
- HOOK $6.77
- Technical
- Relative Strength Index (RSI)
- CVR 49.46
- HOOK 37.62
- Support Level
- CVR $12.04
- HOOK $1.17
- Resistance Level
- CVR $13.00
- HOOK $1.35
- Average True Range (ATR)
- CVR 0.72
- HOOK 0.07
- MACD
- CVR -0.13
- HOOK -0.02
- Stochastic Oscillator
- CVR 40.93
- HOOK 15.75
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.